![](/img/cover-not-exists.png)
EGFR Inhibitor as Second-Line Therapy in a Patient With Mutant RAS Metastatic Colorectal Cancer: Circulating Tumor DNA to Personalize Treatment
Gazzaniga, Paola, Raimondi, Cristina, Urbano, Federica, Cortesi, EnricoLanguage:
english
Journal:
JCO Precision Oncology
DOI:
10.1200/po.17.00277
Date:
April, 2018
File:
PDF, 900 KB
english, 2018